More importantly, in vivo delivery of miR-22-3p in single lipid-based nanoparticles suppresses tumor growth in TNBC models, suggesting that miR-22-3p acts as a tumor suppressor and that delivery of this miRNA into tumors is a potential novel therapy for TNBC. Results miR-22-3p is ...
communication.#Lipopolysaccharide stimulation of astrocytes increased bone morphogenetic protein 2 (BMP2) release, which not only promoted the differentiation of NSCs into astrocytes and inhibited axon remyelination in SCI lesions but also enriched miRNA-22-3p within extracellular vesicles derived from NSCs...
Collectively, SNHG16 accelerated atherosclerotic plaque (AP) formation and enhanced ox-LDL-activated VSMCs proliferation and migration by miRNA-22–3p/HMGB2 axis.doi:10.1016/j.ejphar.2021.174601Yiyong WangDepartment of Cardiovascular Medicine, The First Affiliated Hospital, Xi'an Jiaotong University, ...